+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Kamebakaurin

BP0828
73981-34-7
98%
Biopurify
Kamebakaurin has anti-cancer and anti-inflammatory activities through direct inhibition of DNA-binding activity of nuclear factor-kappa B (NF-κB) p50; it has anti-neuroinflammatory activity via inhibition of c-Jun NH₂-terminal kinase and p38 mitogen-activated protein kinase pathway in activated microglial cells. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity. Kamebakaurin also has the ability to protect the liver from APAP-induced hepatotoxicity, presumably by both inhibiting the inflammatory response and oxidative stress.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0828-10mg 10mg
BP0828-20mg 20mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

STAT3 TNF IKBKB NOD2 PIK3CA MMP9 NFKB1 IL6 IL1B IL17A
BCL2 STAT3 TNF IKBKB PIK3CA MMP9 NFKB1 IL6 IL1B IL17A
BCL2 STAT3 TNF IKBKB PIK3CA MMP9 EGFR NFKB1 IL6 CCND1
BCL2 STAT3 NFKB1 IL6 CCND1 CTSK

Kamebakaurin Related Products

Product drug property prediction parameters

  • 97.9900

  • 1.3238

  • 1.3237

  • .9341

  • 1.5751

  • 11.2636

  • High

  • 48.6520

  • 6.1375

  • No

  • No

  • No

  • No

  • Yes

  • No

  • 0.0

  • Yes

  • No

  • Yes

  • No